Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 715.46B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.4/5 128.56B 17.05 0.73% 18.27%
Gilead Sciences (GILD)
4.2/5 91.62B 7.04 0.13% -20.61%
Anika Therapeutics (ANIK)
4.2/5 727.69M 23.14 1.57% 7.22%
Biogen Inc (BIIB)
4.1/5 61.57B 16.85 -1.32% 7.8%
Regeneron Pharma (REGN)
4.0/5 38.3B 46.88 -2.74% -8.43%
Cambrex (CBM)
4.0/5 1.81B 22.63 2.85% 44.11%
China Biologic Products (CBPO)
4.0/5 2.96B 29.97 -0.94% -6.09%
Celgene (CELG)
3.8/5 91.98B 47.67 -2.42% 14.38%
PDL BioPharma (PDLI)
3.8/5 367.5M 2.09 -2.2% -24.23%
Myriad Genetics (MYGN)
3.8/5 1.29B 22.87 1.93% -46.49%
Innoviva (INVA)
3.8/5 1.25B 22.08 -4.65% -1.2%
Enzo Biochem (ENZ)
3.8/5 308.29M 7.93 -2.63% 57.45%
Emergent Biosolutions (EBS)
3.7/5 1.21B 30.25 -1.45% -16.67%
Illumina (ILMN)
3.7/5 23.41B 51.12 -2.06% 3.02%
Incyte (INCY)
3.7/5 24.85B 242.98 8.9% 76.5%
ANI Pharma (ANIP)
3.7/5 684.03M 85.61 -9.49% 74.04%
AMAG Pharma (AMAG)
3.6/5 800.1M - -3.52% -13.74%
BioTechne Corporation (TECH)
3.6/5 3.98B 50.76 1.28% 22.59%
Alexion Pharma (ALXN)
3.6/5 29.55B 74.74 2.11% -6.15%
Qiagen (QGEN)
3.4/5 6.5B 82.77 -2.6% 30.64%
Integra LifeSciences (IART)
3.4/5 3.17B 54.97 -4.14% 38.04%
Repligen (RGEN)
3.4/5 1.09B 160.65 3.58% 23.34%
Five Prime Therapeutics (FPRX)
3.3/5 1.33B 5.22 -3.32% 42.94%
Horizon Pharma (HZNP)
3.3/5 2.81B - 2.86% -11.82%
Ligand Pharma (LGND)
3.3/5 2.1B 295.24 -5.04% 3.19%
Applied Genetic Technologies (AGTC)
3.2/5 131.11M 12.72 -10.49% -48.98%
Heska (HSKA)
3.2/5 561.36M 65.10 -2.02% 149.1%
Osiris Therapeutics (OSIR) 3.1/5 195M 78.00 -5.98% -21.82%
MiMedx (MDXG)
3.1/5 858.71M 44.25 -3.92% -6.18%
NeoGenomics (NEO)
2.8/5 632.81M - 1% 28.96%
Exelixis (EXEL)
2.7/5 6.21B - -6.19% 463.38%
Cytokinetics (CYTK)
2.6/5 414.28M 34.00 -9.33% 48.91%
Retrophin (RTRX)
2.5/5 768.22M - -1.5% 39.84%
Genomic Health (GHDX)
2.5/5 998.68M - 2.47% 14.69%
Vertex Pharma (VRTX)
2.5/5 21.37B - -2.56% -1.07%
Seattle Genetics (SGEN)
2.5/5 8.94B - -4.23% 102.29%
Acorda Therapeutics (ACOR)
2.4/5 1.15B - -1.58% -24.57%
Alkermes (ALKS)
2.4/5 8.08B - -2.91% 57.63%
BioMarin Pharma (BMRN)
2.4/5 15.05B - -2.63% 9.2%
Vanda Pharmaceuticals (VNDA)
2.4/5 606.47M - -8% 72.5%
Lexicon Pharma (LXRX)
2.4/5 1.64B - -0.13% 73.32%
Amarin (AMRN)
2.3/5 896.24M - -5.41% 128.97%
Kamada (KMDA)
2.3/5 262.24M - 2.06% 107.35%
Halozyme Therapeutics (HALO)
2.3/5 1.59B - -2.7% 48.73%
Array BioPharma (ARRY)
2.2/5 1.78B - -7.12% 306.15%
EXACT Sciences (EXAS)
2.2/5 2.37B - 7.58% 275.79%
Momenta Pharma (MNTA)
2.2/5 1.1B - -18.95% 66.31%
Geron (GERN)
2.2/5 342.16M - -5.7% -14.68%
Organovo (ONVO)
2.2/5 310.1M - 0 35.62
Nymox Pharmaceutical (NYMX)
2.2/5 161.66M - 2.34% 25.45%
Galapagos (GLPG)
2.2/5 3.21B - -0.63% 64.44%
Cellectis (CLLS)
2.2/5 699.58M - -10.54% -12.45%
Keryx Biopharma (KERX)
2.2/5 531.92M - -0.79% 37.91%
Sinovac Biotech (SVA)
2.1/5 323.56M - 0.53% -11.39%
Aduro BioTech (ADRO)
2.1/5 762.52M - -3.81% -24.88%
Uniquire (QURE)
2.1/5 144.58M - -8.87% -60.8%
Coherus Biosciences (CHRS)
2.1/5 1.06B - -3.33% 50.73%
Regenxbio (RGNX)
2.1/5 459.43M - 0.29% 32.65%
Inovio Pharma (INO)
2.0/5 494.73M - -4.02% 2.77%
VIVUS (VVUS)
2.0/5 119.52M - 4.59% 5.56%
NewLink Genetics (NLNK)
2.0/5 413.13M - -7.14% -34.44%
Arna Pharma (ARNA)
2.0/5 357.8M - -1.34% -3.92%
Sorrento Therapeutics (SRNE)
2.0/5 259.5M - -8.11% -18.4%
Alnylam Pharma (ALNY)
1.9/5 4.01B - -3.44% -19.62%
The Medicines Company (MDCO)
1.9/5 3.69B - -2.51% 61.18%
Curis (CRIS)
1.9/5 333.1M - -11.57% 59.06%
Intellia Therapeutics (NTLA)
1.9/5 440.94M - -9.53% -44.57%
Immunomedics (IMMU)
1.9/5 518.73M - -8.43% 124.31%
Celldex Therapeutics (CLDX)
1.9/5 398.63M - -6.59% -57.22%
Compugen (CGEN)
1.9/5 219.87M - -5.49% -9.09%
Merrimack Pharma (MACK)
1.8/5 392.55M - -5.35% -45.86%
Evogene (EVGN)
1.8/5 136.32M - 0.75% -23.13%
Arbutus Biopharma (ABUS)
1.8/5 145.33M - -1.85% -14.24%
Intercept Pharma (ICPT)
1.8/5 2.96B - -7.21% 4.64%
Spark Therapeutics (ONCE)
1.8/5 1.84B - -7.06% 85.8%
Juno Therapeutics (JUNO)
1.8/5 2.27B - -7.31% -41.53%
Cellular Biomedicine (CBMG)
1.8/5 163.89M - -6.5% -34.47%
Acceleron Pharma (XLRN)
1.8/5 950.09M - -6.08% -0.59%
Kite Pharma (KITE)
1.8/5 2.62B - -3.77% 11.04%
Agenus (AGEN)
1.8/5 337.57M - -14.75% 34.44%
Editas (EDIT)
1.8/5 862.88M - -9.53% -14.37%
Mesoblast (MESO)
1.8/5 514.18M - -0.16% 5.61%
Blueprint Medicines (BPMC)
1.7/5 1.12B - -2.45% 93.3%
Stemline Therapeutics (STML)
1.7/5 162.02M - 0.74% 48.27%
Idera Pharma (IDRA)
1.7/5 246.58M - -4.02% -9.73%
Cara Therapeutics (CARA)
1.7/5 410.06M - 1.83% 215.76%
Ophthotech (OPHT)
1.7/5 151.36M - -5.78% -90.92%
bluebird bio (BLUE)
1.7/5 3.35B - 6.36% 64.89%
Adverum (ADVM)
1.7/5 110.56M - -5.36% -52.08%
Acadia Pharma (ACAD)
1.7/5 4.71B - -1.02% 107.58%
CytomX Therapeutics (CTMX)
1.6/5 419.35M - -2.7% -20.22%
ZIOPHARM Oncology (ZIOP)
1.6/5 807.5M - -11.08% -22.19%
Abeona Therapeutics (ABEO)
1.6/5 209.79M - -12.5% 118.75%
Epizyme (EPZM)
1.6/5 704.83M - -5.08% 31.92%
Sangamo BioSciences (SGMO)
1.6/5 282.5M - 0 -26.74
Dynavax Technologies (DVAX)
1.5/5 156.04M - 1.25% -76.68%
OncoMed Pharma (OMED)
1.5/5 338.65M - 4.58% -7.96%
Achillion Pharma (ACHN)
1.5/5 527.59M - -9.6% -47.48%
Prothena (PRTA)
1.5/5 1.84B - -3.21% 53.77%
Revance (RVNC)
1.5/5 578.85M - -3.1% 6.34%
Advaxis (ADXS)
1.5/5 339.43M - -7.64% 45.86%
Proteostasis (PTI)
1.5/5 364.67M - -10.42% 140.3%
Ascendis Pharma (ASND)
1.4/5 909.81M - 2.2% 61.14%
Reata Pharma (RETA)
1.4/5 227.6M - 9.8% 94.57%
Vtv Therapeutics (VTVT)
1.4/5 186.7M - 9.21% -6.41%
MyoKardia (MYOK)
1.4/5 383.43M - -4.31% 72.56%
Adaptimmune Therapeutics (ADAP)
1.4/5 279.6M - -3.89% -49.49%
MediciNova (MNOV)
1.4/5 210.62M - -0.16% 6.27%
NantKwest (NK)
1.4/5 374.81M - -13% -38.6%
Novavax (NVAX)
1.4/5 374.32M - -8.61% -70.7%
Sarepta Therapeutics (SRPT)
1.3/5 1.75B - 13.22% 141.3%
Xenon Pharma (XENE) 1.3/5 138.67M - -6.63% 7.04%
Insmed (INSM)
1.3/5 890.42M - -6.74% 18.93%
MannKind (MNKD)
1.3/5 246.07M - -2.28% -50.1%
Beigene (BGNE)
1.3/5 1.22B - -5.35% 29.65%
Alder BioPharma (ALDR)
1.3/5 1.1B - -6.55% 11.72%
Amicus Therapeutics (FOLD)
1.3/5 850.44M - -4.94% -4.33%
Paratek Pharma (PRTK)
1.3/5 341.68M - -6.21% -2.64%
Trevena (TRVN)
1.2/5 222.64M - -44.04% -56.54%
Intra-Cellular Therapies (ITCI)
1.1/5 554.26M - -3.47% -57.86%
Pfenex (PFNX) - 166.74M 22.97 -8.95% -3.13%
Igene Biotechnology (IGNE) - 0.47M - 0 -100
ARYx Therapeutics (ARYX) - 0.12M - -42.86% 33.33%
Tengion (TNGNQ) - 0.05M - 0 0
Bionovo (BNVIQ) - 0.02M - 0 0
Protein Polymer (PPTIQ) - 0.06M - 0 -100
Wowi (WOWU) - 6.25B - -43.75% 164.71%
Gliatech (GLIAQ) - 0M - N/A N/A
Cellcyte Genetics (CCYG) - 0.12M - 0 -33.33
Viralytics (VRACY) - 196.24M - 0 66.67
Cormedix (CRMD) - 83.28M - -9.25% 14.44%
Williston Holding (WHCA) - 3.93M - 0 900
Neuro Hitech (NHPI) - 0M - 0 0
Atara Bio (ATRA) - 398.28M - -11.54% -19.53%
IR Biosciences (IRBS) - 0M - 0 -100
Addex Therapeutics (ADDXF) - 24.89M - 0 -37.29
Biocoral (BCRA) - 1.23M - N/A N/A
BioTime (BTX) - 360.54M 15.71 11.11% 40.43%
Provectus Biopharma (PVCT) - 9.12M - 31.58% -94.9%
Regenicin (RGIN) - 22.26M - 20.83% 625%
Genitope (GTOPQ) - 0.06M - 0 0
ZYTO Corp (KAEN) - 1.08M - 0 34.78
Mast Therapeutics (MSTX) - 30.57M - -7.69% -57.6%
Deltagen (DGEN) - 0M - 0 -100
Helix Biomedix (HXBM) - 7.84M - -0.21% 0.43%
USA Equities Corp (USAQ) - 0.02M - 0 -96.67
Taxus Cardium Pharma (CRXM) - 2.99M - -14.51% 9%
Marina Biotech (MRNA) - 20.65M - 31.43% 27.78%
GeneLink (GNLKQ) - 0.21M - 0 0
Nanobac Pharma (NNBP) - 0.07M - 0 0
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
Bellus Health (BLUSF) - 11.6M - -2.06% -77.65%
Oncolytics Biotech (ONCYF) - 35.2M - 4.69 0
Protalix Biotherapeutics (PLX) - 111.92M - 3.7% 33.33%
Quick-Med Technologies (QMDT) - 2.43M - 41.3% 550%
Redpoint Bio (RPBC) - 0.07M - 0 0
Health Discovery (HDVY) - 3.26M - 9.09% -60%
Respirerx Pharma (RSPI) - 8.14M - 11.94% -50.03%
NeurogesX (NGSX) - 0.17M - N/A N/A
HedgePath Pharma (HPPI) - 109.57M - -11.43% 210%
iBio (IBIO) - 35.2M - -1.25% -36.29%
Amarillo (AMAR) - 4.49M - -9.09% 16.67%
Ultragenyx Pharma (RARE) - 3.23B - 0.73% 24.35%
Myrexis (MYRX) - 3.45M - 66.67% 25%
Interleukin Genetics (ILIU) - 26.29M - 15% 98.28%
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 87.56M - -6.82% -56.08%
PROTAGENIC THER (PTIX) - 41.04M - -20% -71.25%
Immune Therapeutics (IMUN) - 12.54M - -8.77% -69.41%
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.01M - 0 0
Response Genetics (RGDXQ) - 0.04M - 0 0
Genmab (GNMSF) - 11.89B 108.62 -1.28% 66.6%
Cel-Sci Corporation (CVM) - 19.09M - -4.04% -83.9%
Vital Therapies (VTL) - 147.43M - 0 -45.04
Nicox (NICXF) - 236.3M - 0 28.92
Nutra Pharma (NPHC) - 2.04M 1.14 0 -69.23
DBV Tech (DBVT) - 1.73B - -2.09% 39.22%
ImmunoCellular Therapeutics (IMUC) - 9M - -4.41% -79.69%
International Stem Cell Corp (ISCO) - 5.11M - 25% -56.67%
Advanced Life Sciences (ADLS) - 0M - 0 -100
Theratechnologies (THERF) - 229.27M - 1.87% 177.36%
BioForce Nanosciences (BFNH) - 0.4M - 0 60
Capstone Therapeutics Corp. (CAPS) - 3.35M - 0 9.33
Pathfinder Cell (PFND) - 0.67M - 0 -75
Power 3 Medical (PWRM) - 0.06M - N/A N/A
Regenerx Biopharma (RGRX) - 32.04M - -1.64% -31.66%
Guangzhou Pharma (GZPHY) - 726.88M - 0 0
VG Life Sciences (VGLS) - 1.08M - 42.86% -52.38%
Clovis Oncology (CLVS) - 2.57B - -12.01% 193.91%
Volitionrx (VNRX) - 113.77M - -1.58% 20.78%
DNAPrint Genomics (DNAG) - 0.06M - 0 0
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Arbutus Biopharma (ABUS)
- 145.33M - -1.85% -14.24%
Actelion (ALIOF) - 28.89B - 0.02% 93.41%
Prodite Pharma (PPMD) - 0.12M - 0 -25
Ampliphi Biosciences (APHB) - 7.96M - -8.87% -85.18%